When diagnosed with lung cancer, what are your treatment options? Should surgery be performed first? Are you getting the newest and best treatment? In this episode of Patient Power on HealthNet, Dr. Jyoti Patel, an assistant professor of Medicine in the Division of Hematology/Oncology at the Feinberg School of Medicine at Northwestern University and a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern Memorial Hospital, joins Andrew to answer your questions.
Dr. Patel goes into a detail discussion of drug therapy options for lung cancer, including chemotherapy, EGFR tyrosine kinase inhibitors, Avastin, and oral medications like Tarceva and Iressa. She talks about her approach to treatment and whether it’s best to treat before or after surgery, stressing that each case may be treated differently. You’ll hear why Northwestern Memorial’s multidisciplinary team is so effective and why being treated at a comprehensive cancer center is imperative for a cancer diagnosis.
Dr. Patel also speaks about her optimism for the future of lung cancer treatment. Different approaches are changing the landscape of therapy for this disease. While chemotherapy continues to be the backbone of treatment, other options like vaccine therapy, targeted therapies and combination therapy are interrupting the cellular processes and killing cancer cells. Listen to this program to hear why you should be hopeful about the future.
|
Jyoti Patel, M.D.
Thoracic Oncologist, Northwestern Memorial Hospital
Jyoti Patel, M.D., is an oncologist on the medical staff at Northwestern Memorial Hospital and is the director of the Aerodigestive Malignancy program of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. She is an assistant professor of Medicine in the Division of Hematology/Oncology of Northwestern University’s Feinberg School of Medicine.
more >
|
|
|

